STRO

Sutro Biopharma, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, specializing in the discovery and development of innovative antibody-drug conjugates (ADCs) through its proprietary cell-free protein synthesis technology. The company is focused on advancing a diverse pipeline of targeted therapies aimed at treating cancer and other serious diseases, leveraging its expertise in protein engineering and biologics manufacturing. Sutro's commitment to precision medicine positions it strategically for growth and potential partnerships in the dynamic biopharmaceutical sector, addressing critical unmet medical needs.